J Curtis Nickel1, Alisa Stephens2, J Richard Landis2, Chris Mullins3, Adrie van Bokhoven4, M Scott Lucia4, Garth D Ehrlich5. 1. Department of Urology, Queen's University, Kingston, Ontario, Canada. Electronic address: jcn@queensu.ca. 2. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 3. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 4. Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 5. Departments of Microbiology & Immunology and Otolaryngology-Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Abstract
PURPOSE: We compared culture independent assessment of microbiota of the lower urinary tract in standard culture negative female patients with urological chronic pelvic pain syndrome who reported symptom flare vs those who did not report a flare. MATERIALS AND METHODS: Initial stream (VB1) and midstream (VB2) urine specimens (233 patients with urological chronic pelvic pain syndrome) were analyzed with Ibis T-5000 Universal Biosensor system technology for comprehensive identification of microorganism species. Differences between flare and nonflare groups for presence or number of different species within a higher level group (richness) were examined by permutational multivariate analysis of variance and logistic regression. RESULTS: Overall 81 species (35 genera) were detected in VB1 and 73 (33) in VB2. Mean (SD) VB1 and VB2 species count per person was 2.6 (1.5) and 2.4 (1.5) for 86 flare cases and 2.8 (1.3) and 2.5 (1.5) for 127 nonflare cases, respectively. Overall the species composition did not significantly differ between flare and nonflare cases at any level (p=0.14 species, p=0.95 genus in VB1 and VB2, respectively) in multivariate analysis for richness. Univariate analysis, unadjusted as well as adjusted, confirmed a significantly greater prevalence of fungi (Candida and Saccharomyces) in the flare group (15.7%) compared to the nonflare group in VB2 (3.9%) (p=0.01). When adjusted for antibiotic use and menstrual phase, women who reported a flare remained more likely to have fungi present in VB2 specimens (OR 8.3, CI 1.7-39.4). CONCLUSIONS: Among women with urological chronic pelvic pain syndrome the prevalence of fungi (Candida and Saccharomyces sp.) was significantly greater in those who reported a flare compared to those who did not.
PURPOSE: We compared culture independent assessment of microbiota of the lower urinary tract in standard culture negative female patients with urological chronic pelvic pain syndrome who reported symptom flare vs those who did not report a flare. MATERIALS AND METHODS: Initial stream (VB1) and midstream (VB2) urine specimens (233 patients with urological chronic pelvic pain syndrome) were analyzed with Ibis T-5000 Universal Biosensor system technology for comprehensive identification of microorganism species. Differences between flare and nonflare groups for presence or number of different species within a higher level group (richness) were examined by permutational multivariate analysis of variance and logistic regression. RESULTS: Overall 81 species (35 genera) were detected in VB1 and 73 (33) in VB2. Mean (SD) VB1 and VB2 species count per person was 2.6 (1.5) and 2.4 (1.5) for 86 flare cases and 2.8 (1.3) and 2.5 (1.5) for 127 nonflare cases, respectively. Overall the species composition did not significantly differ between flare and nonflare cases at any level (p=0.14 species, p=0.95 genus in VB1 and VB2, respectively) in multivariate analysis for richness. Univariate analysis, unadjusted as well as adjusted, confirmed a significantly greater prevalence of fungi (Candida and Saccharomyces) in the flare group (15.7%) compared to the nonflare group in VB2 (3.9%) (p=0.01). When adjusted for antibiotic use and menstrual phase, women who reported a flare remained more likely to have fungi present in VB2 specimens (OR 8.3, CI 1.7-39.4). CONCLUSIONS: Among women with urological chronic pelvic pain syndrome the prevalence of fungi (Candida and Saccharomyces sp.) was significantly greater in those who reported a flare compared to those who did not.
Authors: Evann E Hilt; Kathleen McKinley; Meghan M Pearce; Amy B Rosenfeld; Michael J Zilliox; Elizabeth R Mueller; Linda Brubaker; Xiaowu Gai; Alan J Wolfe; Paul C Schreckenberger Journal: J Clin Microbiol Date: 2013-12-26 Impact factor: 5.948
Authors: Tykeysha Powell-Boone; Timothy J Ness; Ronda Cannon; L Keith Lloyd; Douglas A Weigent; Roger B Fillingim Journal: J Urol Date: 2005-11 Impact factor: 7.450
Authors: Michael P Palmer; Daniel T Altman; Gregory T Altman; Jeffrey J Sewecke; Garth D Ehrlich; Fen Z Hu; Laura Nistico; Rachel Melton-Kreft; Trent M Gause; John W Costerton Journal: J Orthop Trauma Date: 2014-07 Impact factor: 2.512
Authors: Meghan M Pearce; Evann E Hilt; Amy B Rosenfeld; Michael J Zilliox; Krystal Thomas-White; Cynthia Fok; Stephanie Kliethermes; Paul C Schreckenberger; Linda Brubaker; Xiaowu Gai; Alan J Wolfe Journal: MBio Date: 2014-07-08 Impact factor: 7.867
Authors: David J Ecker; Rangarajan Sampath; Christian Massire; Lawrence B Blyn; Thomas A Hall; Mark W Eshoo; Steven A Hofstadler Journal: Nat Rev Microbiol Date: 2008-06-03 Impact factor: 60.633
Authors: J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis Journal: Nat Rev Urol Date: 2019-03 Impact factor: 14.432
Authors: Siobhan Sutcliffe; Thomas Jemielita; H Henry Lai; Gerald L Andriole; Catherine S Bradley; J Quentin Clemens; Robert Gallop; Thomas M Hooton; Karl J Kreder; John N Krieger; John W Kusek; Jennifer Labus; M Scott Lucia; Sean Mackey; Bruce D Naliboff; Nancy A Robinson; Larissa V Rodriguez; Alisa Stephens-Shields; Adrie van Bokhoven; Kathleen Y Wolin; Yan Yan; Claire C Yang; J Richard Landis; Graham A Colditz Journal: J Urol Date: 2017-12-27 Impact factor: 7.450